Actively Recruiting
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Led by University Health Network, Toronto · Updated on 2025-04-16
40
Participants Needed
1
Research Sites
140 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to test radiofrequency ablation (RFA) in thyroid cancers ≤2 cm in diameter. The main question it aims to answer is: • What is the feasibility of RFA use for low-risk thyroid cancers (≤2 cm)? Participants will undergo a set of pre-procedural scans of the target thyroid nodule and undergo the RFA procedure/intervention. Then, participants will partake in three follow-up appointments at 4 weeks, 6 months, and 12 months post-procedure as per standard of care.
CONDITIONS
Official Title
The Safety and Feasibility of Radiofrequency Ablation to Treat Low-risk Thyroid Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with thyroid nodules 2 cm or smaller in size
- Nodules classified as Bethesda 5 or 6
- Age 18 years or older and up to 100 years
- Able to provide written consent
- Able to attend all required follow-up visits as outlined in the protocol
You will not qualify if you...
- Patients younger than 18 years old
- Pregnant women
- Any concern for invasive or metastatic thyroid cancer
- Previously treated for thyroid cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Health Network
Toronto, Ontario, Canada, M5G2C4
Actively Recruiting
Research Team
J
Jesse Pasternak
CONTACT
E
Emily Saso
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here